Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome Carolyn E. Cesta, M.Sc., Alexander Viktorin, Ph.D., Henrik Olsson, M.Sc., Viktoria Johansson, Ph.D., Arvid Sjölander, Ph.D., Christina Bergh, M.D., Alikistis Skalkidou, Ph.D., Karl-Gösta Nygren, M.D., Sven Cnattingius, Ph.D., Anastasia N. Iliadou, Ph.D. Fertility and Sterility Volume 105, Issue 6, Pages 1594-1602.e3 (June 2016) DOI: 10.1016/j.fertnstert.2016.01.036 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Flowchart of the exclusion of cycles recorded between 2007 and 2012 in the Swedish National Quality Register of Assisted Reproduction. Fertility and Sterility 2016 105, 1594-1602.e3DOI: (10.1016/j.fertnstert.2016.01.036) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions
Figure 2 The odds of (A) pregnancy after an IVF cycle, (B) live birth after an IVF cycle, (C) live birth after pregnancy, and (D) miscarriage after pregnancy in exposed women compared with women in the reference group. Analysis adjusted for age at cycle start, birth country, and evidence of psychosis. SSRI = selective serotonin reuptake inhibitor; OR = odds ratio; CI = confidence interval. Fertility and Sterility 2016 105, 1594-1602.e3DOI: (10.1016/j.fertnstert.2016.01.036) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions